u/cohhen

5 theses · first seen Sep 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d
3d
1w
1m
3m
6m
1y

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ENVXr/pennystocksDDbullish
u/cohhen · 77d ago4 prior · awaiting results

$ENVX — The Next 300% Runner: MAR to JUL 2026 Catalysts (A Routine Runner)

Enovix shows a recurring July-August seasonal rally pattern (300%+ over the past 4 years) driven by production milestones and revenue acceleration. The company's silicon-anode architecture and manufacturing expertise position it well for on-device AI demand and potential solid-state battery transition, with near-term catalysts including 2H 2026 Honor smartphone deployment and Malaysia Fab-2 production ramp.

At post $5.36Now $2.93-45.4% since posted18m ago
1d
3d
1w+0.7%
1m-23.7%
3m
6m
1y
original post →
$DFLIr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish
u/cohhen · 337d ago4 prior · awaiting results

$DFLI TO $3.00 EOD: Granted Patent

Dragonfly Energy received a USPTO patent allowance for its battery communication technology covering mesh networking and data propagation. The patent strengthens the company's IP portfolio and is linked to its Battle Born HUB product, positioning the company for growth.

At post $13.60Now $0.89-93.4% since posted18m ago
original post →
$MNTSr/pennystocksDDbullish
u/cohhen · 342d ago4 prior · awaiting results

Today's Dips Are Blessings In Disguise: $GPUS; $INTS; $MNTS; $MIST

MNTS is a commercial space infrastructure company developing in-space transportation vehicles and hosted payload services; recent NASA contract wins ($2.5M thruster, $5.1M materials production) validate its technology and provide non-dilutive funding. Operating leverage in space logistics and a low-tens-of-millions market cap create significant upside potential if OSV deployments and recurring payload revenue execute.

Now $4.4017m ago
original post →
$INTSr/pennystocksDDbullish
u/cohhen · 342d ago4 prior · awaiting results

Today's Dips Are Blessings In Disguise: $GPUS; $INTS; $MNTS; $MIST

INTS is a late-stage biotech with its DfuseRx platform combining localized chemotherapy and immune activation, running Phase 3 STS and Phase 2 TNBC trials with prior data showing mOS of 21.3 months versus 6.7 months control. At ~$15–16M market cap with readouts expected through 2026, the company presents asymmetric upside if trials succeed or partnership/funding catalysts accelerate.

At post $6.53Now $3.83-41.3% since posted18m ago
original post →
$GPUSr/pennystocksDDbullish
u/cohhen · 342d ago4 prior · awaiting results

Today's Dips Are Blessings In Disguise: $GPUS; $INTS; $MNTS; $MIST

GPUS is transforming into an AI data infrastructure and Bitcoin mining operator with a cleaned balance sheet ($30M debt elimination), dual revenue streams, and an existing 617,000 sq ft facility being expanded. The company has ordered 1,000 Bitcoin miners scaling to 5,000 units (20MW) while pursuing a $100M on-balance-sheet Bitcoin treasury strategy, presenting a significant valuation disconnect given the micro-cap ($12M) versus Bitcoin holdings alone.

Now $0.1818m ago
original post →

End of results.